Article Details

Adaptimmune Therapeutics (ADAP) Lowered to Market Perform at Leerink Swann

Retrieved on: 2019-05-15 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

Adaptimmune Therapeutics (ADAP) Lowered to Market Perform at Leerink Swann. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> lifted its stake in shares of Adaptimmune Therapeutics by 28.2% during the 1st quarter. <b>Man Group plc</b> now owns 1,338,630 shares of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo